Barclays Upgrades Ionis Pharmaceuticals (IONS) to Equalweight

March 1, 2021 2:43 AM EST
Get Alerts IONS Hot Sheet
Price: $42.46 +2.34%

Rating Summary:
    8 Buy, 9 Hold, 3 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 18 | Down: 10 | New: 17
Trade Now! 
Join SI Premium – FREE

Barclays analyst Gena Wang upgraded Ionis Pharmaceuticals (NASDAQ: IONS) from Underweight to Equalweight with a price target of $52.00 (from $50.00).

For an analyst ratings summary and ratings history on Ionis Pharmaceuticals click here. For more ratings news on Ionis Pharmaceuticals click here.

Shares of Ionis Pharmaceuticals closed at $52.40 yesterday.

You May Also Be Interested In

Related Categories

Analyst PT Change, Hot Upgrades, Upgrades